Literature DB >> 15589775

Validating a pencil-and-paper measure of perimenopausal menstrual blood loss.

Phyllis Kernoff Mansfield1, Ann Voda, Gary Allison.   

Abstract

In the study presented here, we describe our efforts to develop and validate a new measurement tool for perimenopausal menstrual blood loss. We validate this simple-to-use, subjective pencil-and-paper scale, the Mansfield-Voda-Jorgensen Menstrual Bleeding Scale (MVJ), against an objective measure, the weight of used menstrual products. Thirty-one women from the Minneapolis-St. Paul, MN region saved all their used products over three menstrual cycles, storing them in airtight zip bags, and rated their menstrual fluid volume loss using the MVJ. The overall correlation between MVJ scores and log discharge rate was quite high (r = 0.683); all MVJ categories were statistically unique with the exception of categories "1" and "2." The overall fit, then, was particularly good at the heavy bleeding end of the scale. When five women with poor performance were removed, the correlations ranged from 0.480-0.894. The MVJ is a promising tool for identifying women with excessive menstrual bleeding. It is a simple-to-use, pencil-and-paper scale that offers an inexpensive and practical method to clinicians who work with perimenopausal women, the group most vulnerable to unnecessary worry and/or interventions when menorrhagia is incorrectly diagnosed.

Entities:  

Mesh:

Year:  2004        PMID: 15589775     DOI: 10.1016/j.whi.2004.07.005

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  10 in total

1.  Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study.

Authors:  Ritchard G Cable; Simone A Glynn; Joseph E Kiss; Alan E Mast; Whitney R Steele; Edward L Murphy; David J Wright; Ronald A Sacher; Jerry L Gottschall; Vibha Vij; Toby L Simon
Journal:  Transfusion       Date:  2010-08-30       Impact factor: 3.157

2.  Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort.

Authors:  Sybil L Crawford; Nancy E Avis; Ellen Gold; Janet Johnston; Jennifer Kelsey; Nanette Santoro; MaryFran Sowers; Barbara Sternfeld
Journal:  Am J Epidemiol       Date:  2008-10-25       Impact factor: 4.897

3.  Menorrhagia: a synopsis of management focusing on herbal and nutritional supplements, and chiropractic.

Authors:  Anna B Livdans-Forret; Phyllis J Harvey; Susan M Larkin-Thier
Journal:  J Can Chiropr Assoc       Date:  2007-12

Review 4.  Abnormal uterine bleeding: a review of patient-based outcome measures.

Authors:  Kristen A Matteson; Lori A Boardman; Malcolm G Munro; Melissa A Clark
Journal:  Fertil Steril       Date:  2008-07-16       Impact factor: 7.329

5.  Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.

Authors:  Bruce R Carr; Elizabeth A Stewart; David F Archer; Ayman Al-Hendy; Linda Bradley; Nelson B Watts; Michael P Diamond; Jingjing Gao; Charlotte D Owens; Kristof Chwalisz; W Rachel Duan; Ahmed M Soliman; Matthew B Dufek; James A Simon
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

6.  Laparoscopic Surgery for Focal Adenomyosis.

Authors:  Jae-Young Kwack; Yong-Soon Kwon
Journal:  JSLS       Date:  2017 Apr-Jun       Impact factor: 2.172

7.  A systematic review of methods to measure menstrual blood loss.

Authors:  Julia L Magnay; Shaughn O'Brien; Christoph Gerlinger; Christian Seitz
Journal:  BMC Womens Health       Date:  2018-08-22       Impact factor: 2.809

8.  Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.

Authors:  Juliawati Muhammad; Yusnita Yusof; Imran Ahmad; Mohd Noor Norhayati
Journal:  BMC Womens Health       Date:  2022-01-15       Impact factor: 2.809

9.  Effects of pelvic endometriosis and adenomyosis on ciliary beat frequency and muscular contractions in the human fallopian tube.

Authors:  Wei Xia; Duo Zhang; Jing Ouyang; Yan Liang; Huiyu Zhang; Zhen Huang; Guiling Liang; Qian Zhu; Xiaoming Guan; Jian Zhang
Journal:  Reprod Biol Endocrinol       Date:  2018-05-12       Impact factor: 5.211

10.  Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.

Authors:  James A Simon; Ayman Al-Hendy; David F Archer; Kurt T Barnhart; Linda D Bradley; Bruce R Carr; Thomas Dayspring; Eve C Feinberg; Veronica Gillispie; Sandra Hurtado; JinHee Kim; Ran Liu; Charlotte D Owens; Ozgul Muneyyirci-Delale; Alice Wang; Nelson B Watts; William D Schlaff
Journal:  Obstet Gynecol       Date:  2020-06       Impact factor: 7.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.